SCHEMBL25952316

SCHEMBL25952316

Cn1cnc(=O)c2ccc(-c3nc(-c4cc(=O)c5ccc(-c6nccnc6Oc6ccc(C(F)(F)F)cc6)cc5n4C)cnc3Sc3ccc(C(F)(F)F)cc3)cc21

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544122 0.79 TRPV1 (0.37) —
SCHEMBL25954052 0.79 TRPV1 (0.37) —
SCHEMBL25430689 0.74 PDE10A (0.42) PDE10A
SCHEMBL25429595 0.72 TRPV1 (0.37) —
SCHEMBL30544064 0.69 PDE10A (0.43) PDE10A
SCHEMBL25431600 0.69 PDE10A (0.43) PDE10A
SCHEMBL25433941 0.64 PDE10A (0.35) PDE10A
SCHEMBL25429893 0.63 HSD17B10 (0.54) PDE10A
SCHEMBL25430344 0.62 TRPV1 (0.41) —
SCHEMBL25430317 0.60 HSD17B10 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback